Steroids in treatment of pertussis: A controlled clinical trial
| Autor: | D. Anagnostakis, N. Matsaniotis, V. Albanis, D. Zoumboulakis |
|---|---|
| Rok vydání: | 1973 |
| Předmět: |
Male
Pediatrics medicine.medical_specialty Time Factors Hydrocortisone Vomiting Whooping Cough Erythromycin Leukocyte Count Sex Factors Sex factors medicine Humans Lung Clinical Trials as Topic business.industry Age Factors Infant Newborn Infant Original Articles Cortisone Radiography Clinical trial Pediatrics Perinatology and Child Health Female Immunization medicine.symptom business medicine.drug |
| Zdroj: | Archives of Disease in Childhood. 48:51-54 |
| ISSN: | 1468-2044 0003-9888 |
| DOI: | 10.1136/adc.48.1.51 |
| Popis: | Of 135 children with pertussis 70 were treated with steroids for 7 to 8 days and the remainder served as controls. The two groups were comparable. All children received erythromycin for 10 days. They were in the first week of the paroxysmal stage. Coughing, whooping, and vomiting episodes occurred less frequently in the steroid-treated groups, and the illness was shorter especially in babies under 1 year of age. These results indicate that steroids may have a beneficial effect on the course of pertussis if given early in the paroxysmal stage. Nevertheless, since steroids are potentially dangerous drugs we believe their use in pertussis must be limited to severe cases, particularly in infants under 6 to 9 months of age where the mortality is highest. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|